3.9 Article

985 ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide

Journal

EUROPEAN UROLOGY SUPPLEMENTS
Volume 11, Issue 1, Pages e985-e985a

Publisher

Elsevier BV
DOI: 10.1016/s1569-9056(12)60981-6

Keywords

-

Categories

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available